Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2001
10/04/2001WO2001072742A1 Bisamidino compounds as nhe-3 inhibitors
10/04/2001WO2001072725A1 BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa
10/04/2001WO2001072712A1 ISOQUINOLONE INHIBITORS OF FACTOR Xa
10/04/2001WO2001072708A2 OXINDOLE INHIBITORS OF FACTOR Xa
10/04/2001WO2001072705A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/04/2001WO2001072703A1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
10/04/2001WO2001072702A2 Amidino compounds useful as nitric oxide synthase inhibitors
10/04/2001WO2001072669A2 Therapeutic use of polyhydroxy amine derivates
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072311A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001WO2001072308A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001WO2001072293A2 Antiprogestins with partial agonist activity
10/04/2001WO2001072279A2 Medical emulsion for lubrication and delivery of drugs
10/04/2001WO2001019828A3 Kinase inhibitors as therapeutic agents
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001005764A3 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester
10/04/2001WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
10/04/2001US20010027177 Pharmaceutical composition containing a small or medium size peptide
10/04/2001US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets
10/04/2001US20010026928 Monoclonal antibodies as well as homologues, analogues, and modified and derived forms thereof, immunoglobin fab fragments, single chain antibodies; treating pathological inflammation and autoimmune diseases
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001EP1138694A1 Hirulog-like peptide
10/04/2001EP1138680A1 Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
10/04/2001EP1137797A1 Expression system for factor viii
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137653A1 Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same
10/04/2001EP1137642A1 Bis-sulfonamides
10/04/2001EP1137640A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
10/04/2001EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
10/04/2001EP1137446A1 Collagen hemostatic foam
10/04/2001EP1137432A1 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/04/2001EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives
10/04/2001EP1137408A1 Agent for lowering endothelin levels
10/04/2001EP1137405A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
10/04/2001EP1137402A1 Phospholipid compositions
10/04/2001EP0821685B1 Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
10/04/2001EP0815123B1 Beta-sheet mimetics and use thereof as protease inhibitors
10/04/2001EP0809635B1 Alpha-substituted hydrazides having calpain inhibitory activity
10/04/2001EP0639979B1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
10/04/2001DE10015939A1 Thrombolytic agent useful e.g. for treating or preventing deep vein leg thrombosis, pulmonary embolism or restenosis comprises new or known 3-phenyl-4,5-dihydro-2-phenylbenz(e)indole derivatives
10/04/2001DE10015248A1 Bisamidino-Verbindungen als NHE-3 Inhibitoren Bisamidino compounds as NHE-3 inhibitors
10/04/2001CA2404901A1 Composition and method for intervening neuronal death using sulfasalazine
10/04/2001CA2404780A1 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001CA2404478A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
10/04/2001CA2404411A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001CA2404231A1 Methods of treating diseases with activated protein c
10/04/2001CA2404172A1 Antiprogestins with partial agonist activity
10/04/2001CA2404157A1 Inhibition of a novel calcium injury current that forms in neurons during injury prevents neuronal cell death
10/04/2001CA2403787A1 Il-8 receptor antagonists
10/04/2001CA2403515A1 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001CA2402735A1 Human transcription factors
10/04/2001CA2401242A1 Pharmaceutically active pyrrolidine derivatives
10/04/2001CA2399875A1 Crystal structure of the (aml1 runt domain) / (cbfbeta) heterodimer and the ternary complex with dna
10/04/2001CA2374911A1 G-protein coupled receptors
10/03/2001CN1315942A 2-oxo-j(2H)-quinoline derivatives
10/03/2001CN1315873A Prevention/remedies for multiple organ failure
10/03/2001CN1315863A Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
10/03/2001CN1315856A Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
10/03/2001CN1315855A Immediate release tablet
10/03/2001CN1315205A Batong oral liquid
10/03/2001CN1315199A Medicine for regulating blood fat and reducing plasma fibrin
10/03/2001CN1072220C 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derives as neurokinin receptor antagonists
10/03/2001CN1072015C Medicine for treating hydrocephalus
10/02/2001US6297381 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor, ureas or thioureas substituted by a pyrrole or thiophene
10/02/2001US6297265 Benzoisothiazole-substituted compounds useful as IL-8 receptor antagonists
10/02/2001US6297261 Potent chloride channel blockers; treatment of sickle cell anemia, brain edema following ischaemia or tumors, diarrhea, hypertension (diuretic), osteoporosis, and for the reduction of the intraocular pressure
10/02/2001US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/02/2001US6297238 3-aryl pyrazoles with 4,5(3,4)-bicyclic ring fusion which are inhibitors of protein kinases particularly tyrosine kinases and serine/threonine kinases
10/02/2001US6297234 Arylthiophene vasopressin agonists
10/02/2001US6297233 Lactam inhibitors of FXa and method
10/02/2001US6297232 Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments
10/02/2001CA2086243C Anticoagulant peptides
10/02/2001CA2078000C Neutrophil stimulating peptides
10/02/2001CA2076647C Branched fructo-oligosaccharides, a method for obtaining them and uses of products containing them
10/02/2001CA2035917C Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
09/2001
09/30/2001CA2340461A1 Hirulog-like peptide and gene therapy
09/27/2001WO2001071004A2 Proteases
09/27/2001WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
09/27/2001WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof
09/27/2001WO2001070968A2 Production of recombinant blood clotting factors in human cell lines
09/27/2001WO2001070818A1 Anti-c2/c2a inhibitors of complement activation
09/27/2001WO2001070807A2 G-protein associated molecules
09/27/2001WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein
09/27/2001WO2001070740A1 Process for preparing crystalline form i of cabergoline
09/27/2001WO2001070738A2 Tri-aryl-substituted-ethane pde4 inhibitors
09/27/2001WO2001070736A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants
09/27/2001WO2001070734A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
09/27/2001WO2001070723A1 Benzothiophene derivatives and medicinal use thereof
09/27/2001WO2001070709A2 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity
09/27/2001WO2001070695A1 Pyridine derivatives as inhibitors of p38
09/27/2001WO2001070694A1 Amorphous torasemide modification
09/27/2001WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
09/27/2001WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
09/27/2001WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
09/27/2001WO2001070273A1 The use of anticoagulant agents in the extracorporeal treatment of blood
09/27/2001WO2001070254A1 Use of human not1 and not1a orphan receptors
09/27/2001WO2001070229A1 Thrombin inhibitors
09/27/2001WO2001070219A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
09/27/2001WO2001070214A2 The use of cocoa procyanidins combined with acetylsalicyclic acid as an anti-platelet therapy
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 671